Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.